Dr. Liapakis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
403 E 34th St
Fl 3
New York, NY 10016Phone+1 212-263-8133Fax+1 929-455-9850
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Transplant Hepatology, 2011 - 2012
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2008 - 2011
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2005 - 2008
- Albert Einstein College of MedicineClass of 2005
Certifications & Licensure
- NY State Medical License 2006 - 2026
- CT State Medical License 2012 - 2025
- ND State Medical License Active through 2012
Clinical Trials
- Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study Start of enrollment: 2019 Jul 01
Publications & Presentations
PubMed
- 56 citationsDrug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade.Albert Do, Yash Mittal, AnnMarie Liapakis, Elizabeth Cohen, Hong Chau
Plos One. 2015-08-27 - 21 citationsEquitable access to liver transplant: Bridging the gaps in the social determinants of health.Russell Rosenblatt, Hannah Lee, AnnMarie Liapakis, Keri E Lunsford, Andrew Scott
Hepatology. 2021-06-01 - 223 citationsSafety and efficacy of sofosbuvir‐containing regimens in hepatitis C‐infected patients with impaired renal functionVarun Saxena, Farrukh M. Koraishy, Meghan E. Sise, Joseph K. Lim, Monica Schmidt
Liver International. 2016-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: